Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?

J Allergy Clin Immunol. 2022 May;149(5):1582-1584. doi: 10.1016/j.jaci.2022.01.019. Epub 2022 Feb 8.
No abstract available

Keywords: Allergic effector unit; TSLP; airway hyperresponsiveness; allergic inflammation; asthma; eosinophils; mast cells.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Cytokines
  • Eosinophils*
  • Humans
  • Leukocyte Count

Substances

  • Antibodies, Monoclonal, Humanized
  • Cytokines
  • tezepelumab